Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1

Nature News ·

Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1

Study sponsorship, authorizations and ethics This study was an investigator initiated trial sponsored by Gustave Roussy and covered by a Biomedical Research Promoter Civil Liability insurance …

Study sponsorship, authorizations and ethics This study was an investigator initiated trial sponsored by Gustave Roussy and covered by a Biomedical Research Promoter Civil Liability insurance contract (contract 124.895) in accordance with the provisions of the French law (Decree 2006-477 of 26 April 2006 and Article L.1121-10 of the French Public Health Code). …

Original source: Nature News